phosphotyrosine has been researched along with Hepatitis C, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auernhammer, CJ; Beigel, F; Brand, S; Dambacher, J; Diepolder, H; Eichhorst, ST; Göke, B; Olszak, T; Vlotides, G; Zitzmann, K | 1 |
1 other study(ies) available for phosphotyrosine and Hepatitis C, Chronic
Article | Year |
---|---|
SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29.
Topics: 2',5'-Oligoadenylate Synthetase; Antiviral Agents; Cell Line, Tumor; Cytokines; DNA-Binding Proteins; Gene Expression; Gene Expression Regulation; GTP-Binding Proteins; Hepatitis C, Chronic; Humans; Interferons; Interleukins; Intracellular Signaling Peptides and Proteins; Myxovirus Resistance Proteins; Phosphorylation; Phosphotyrosine; Repressor Proteins; STAT1 Transcription Factor; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins; Trans-Activators | 2005 |